Keywords: Interleukin-6 (IL-6); Metabolic disease; IL-6; interleukin-6; MS; metabolic syndrome; ROS; reactive oxygen species; IFN; interferon; hIL-6; human interleukin-6; SHP-2; Src homology domain-containing protein tyrosine phosphatase-2; IR; insulin resistance;